Capital Market Lawyers
Capital Market Lawyers

Capital Market lawyers

Capital Markets lawyers advising companies, nomads, brokers and investors on AIM, AQSE and the Standard List.

Capital Market lawyers acting together with market professionals and advisers.

Our Capital Markets experts are on hand to advise you in relation to capital markets transactions and listing requirements.

Our Capital Markets team has experience with clients listed on the Main Market, AIM, the Aquis Exchange and the International Securities Market. We act for issuers, brokers, nominated advisers, and investors with a particular focus on transactions involving growth companies with a quotation on AIM, the Aquis Exchange or a Standard Listing.

We have the expertise to advise you in relation to capital markets transactions, IPOs, reverse takeovers and secondary fundraisings. We also advise on ongoing listing requirements,market rules, corporate governance, AGMs, and general corporate law matters.

Our track record

Oxford Metrics plc on £52m sale of Yotta.

...
Oxford Metrics plc | Yotta | Causeway Technologies
We have recently advised Oxford Metrics plc on the sale of Yotta to Causeway Technologies for £52m. Oxford Metrics, a long-standing client of RWK Goodman, is an Oxford-based smart sensing software company with customers across the life sciences, entertainment and engineering sectors.
More
Less

Advised on the admission of Helium Ventures plc (SPAC) to trading on AQSE.

...
Cairn Financial Advisers LLP | Pello Capital Limited | Helium Ventures plc | Aquis Stock Exchange Growth Market
advised Cairn Financial Advisers LLP (AQSE Corporate Adviser) and Pello Capital Limited (Broker) on the admission of Helium Ventures plc - a SPAC (Special Purpose Acquisition Vehicle) - to trading on the Access segment of the Aquis Stock Exchange Growth Market.
More
Less

£21 million acquisition of Cizzle Biotechnology Limited, Bould’s associated £2.2m fundraising and the admission of the enlarged group to trading on the Main Market of the London Stock Exchange.

...
Bould Opportunities plc | Cizzle Biotechnology Limited
RWK Goodman advised Bould Opportunities plc on its £21 million acquisition of Cizzle Biotechnology Limited and admission of the enlarged group to Main Market of the London Stock Exchange
More
Less

Advised on the admission of Quantum Exponential Group plc to the AQSE Growth Market Access Segment.

...
Quantum Exponential Group plc | AQSE Growth Market Access Segment
Advised Novum Securities and Oberon Investment Group, as corporate adviser and broker respectively, in relation to the admission of Quantum Exponential Group plc to the AQSE Growth Market Access Segment.
More
Less

Advised on Hydrogen Future Industries PLC's AQSE IPO.

...
Cairn | Peterhouse Capital | Hydrogen Future Industries plc
Advised Cairn as AQSE Corporate Adviser and Peterhouse Capital as broker in relation to the admission of Hydrogen Future Industries plc (AQSE:HFI) to the Access Segment of the AQSE Growth Market.
More
Less

Advised on the £15.84 million reverse takeover acquisition of Capital Metals Limited.

...
Spark Advisory Partners | Brandon Hill Capital
Financed through a combination of an oversubscribed placing, management subscriptions and the issue by EPO of up to 132,000,000 new ordinary shares as consideration to the CML shareholders for all the issued shares in CML.
More
Less

TomCo Energy plc in relation to its placing to raise £3.5m.

...
TomCo | Valkor LLC | Greenfield
Advised TomCo Energy plc (AIM: TOM) in relation to its placing to raise £3.5m. The placing enables TomCo to progress the development of its 50/50 joint venture with Valkor LLC, Greenfield Energy LLC, and for Greenfield to enter into a new technology license with Petroteq Energy Inc. (TSXV:PQFF).
More
Less
Latest from the info hub

Insights and opinions

View more articles related to Corporate